Ms Amalina Ridzuan, Phase III Medicine student, is one of the first two former madrasah students to be accepted by the school in 2015.
A new way of building protective suits for proteins has been developed by a team led by Dr Chester Drum from Department of Medicine at NUS Yong Loo Lin School of Medicine, and this finding may help with future treatment of diseases such as cancer.
A research team led by National University Health System (NUHS) and Duke-NUS Medical School has used genomic technologies to better understand intestinal metaplasia (IM), a known risk factor for gastric (stomach) cancer. Patients with IM are six times more likely to develop stomach cancer than those without.
Eight immunotherapy trials are currently ongoing as part of the National University Health System (NUHS)’s Cancer Summit Research Programme, aimed at targeting a range of cancers including breast cancer and lymphoma.
NCIS Oncology Grand Round: Tips for a Successful Clinical Scientist Career in Academia
Workshop: Postgraduate Safety Training Course
Grand Round: From PEACE Effort to GAP Tool - Making Care Planning Conversations Available